Home Combined FDA authorizes new Covid-19 treatment

FDA authorizes new Covid-19 treatment

SHARE

The U.S. Food and Drug Administration late Thursday afternoon issued an emergency use authorization to Eli Lilly and Co. to allow use of its drug baricitinib in combination with the drug remdesivir to treat COVID-19. The drug combination can be used in hospitalized adults and pediatric patients 2 years or older requiring oxygen or invasive…

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email